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Introduction
Hepatic and skeletal muscle glycogen content in rats treated with 
metformin and submitted to acute exercise by swimming
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Abstract
The aim of this study was to evaluate the behavior of glycogen reserves over an acute exercise condition 
(50 minutes of swimming at low intesity), after treatment with metformin in rats. Forty Wistar rats (180-
200g) adults were divided into four groups (treated or not for a fortnight) and represented as follows: 
Control; Acute exercise by swimming (perform a session of swimming, 50 min on light intensity); Treated 
with metformin (received the drug metformin at a dose 1.4 mg/ml during the experimental period; Treated 
with metformin and exercised by swimming (received the drug metformin at a dose 1.4 mg/ml and held a 
swimming, 50 min on light intensity). The acute exercise decreased the glycogen reserves, while animals 
treated with metformin showed an increase in their muscle and liver glycogen reserves (p>0,05). Additionally, 
the drug showed no increase glucose and corticosterone concentration compared to the control and treated 
with metformin groups (p>0,05). Treatment with metformin improved energy conditions and lowers the 
stress response, suggesting that an important pharmacological tool for the potentiation of performance. 
Keywords: Glycogen; Performance; Biguanide; Rats.
Recent studies have demonstrated the multi-
factorial action of the biguanide metformin, while 
pharmacological agent widely used in glycemic 
control in patients with diabetes mellitus1-2. With-
in the broad spectrum of action of the substance, 
deserves spotlight the reduction in the production/
release of liver reserves of glucose (gluconeogene-
sis, glycogenolysis), increased insulin sensitivity in 
(especially in muscles) peripheral tissues, increased 
peripheral glucose utilization (by capture glucose 
and insulin-stimulated glycogen synthesis) and in-
crease the population of insulin receptors (reducing 
hyperinsulinemia) without weight gain3-4.
Metformin formula was first published by 
Ungar et al.5 and used primarily by Mahler et 
al.6 in patients with type 2 diabetes mellitus, being 
introduced for use in insulin resistant states, even 
before the development of hyperglycemia7. Ac-
cording to Diabetes Prevention Program Research 
Group8, its effects include anti-hyperglycemic action 
without risk of severe hypoglycemia and a reversal 
of the insulin resistance process.
Metformin activates AMP-activated protein 
kinase (AMPK) that promotes glucose utilization9, 
an increase in AMPK activity is associated with 
increased translocation of glucose transporter 
(GLUT)-4 to the plasma membrane, increase in 
hexokinase activity and glycogen content in cells 
muscle, in addition, there is increased oxidation of 
fatty acids10.
Inside the metabolic profile of skeletal muscle, it 
is known that preferentially uses glucose as energy 
substrate, which is captured in basal conditions by 
the carrier glucose GLUT-1 whose action is not 
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dependent on insulin or the GLUT-4 that can be 
translocated from cytosolic reservoirs for membrane 
through the action of insulin or by the increase in 
contractile activity11. After uptake, glucose can be 
oxidized or reserved in the form of glycogen, while 
important determinant of the efficiency of reservoir 
contractile process, reaching minimum values  when 
the muscle goes into fatigue11.
The antihyperglycaemic activity of metformin is 
related mainly to the suppression of gluconeogene-
sis, block in glycogenolysis, reduction of intestinal 
glucose absorption, increased kinase activity of the 
insulin receptor, stimulation of post-insulin recep-
tor pathways, increased translocation of GLUT-4, 
glucose uptake consequent elevation of the enzyme 
glycogen synthase activity leading to induction of the 
formation of large reserves of glycogen12-13. Emerging 
hypothesis to evaluate whether the drug promotes in-
creased metabolic resistance against physical exercises.
When considering the metabolic changes pro-
vided by the use of metformin, which promotes a 
rise in the glycogen content, the hypothesis arises 
that the previous use of metformin, at doses like 
those commonly prescribed for diabetics, may 
provide adjustments in energy metabolism that 
may be important in the practice of physical exer-
cise. Thus the aim of this study was to evaluate, in 
rats eutrophics and previously treated with met-
formin, the behavior of glycogen reserves over a 
acute exercise during 50 minutes of swimming in 
low intensity. We emphasize that, in spite of that 
medication be prescribed for diabetics, recently, 
eutrophic individuals who begin to perform phys-
ical activity have indiscriminately used it. These 
individuals use the drug as a result of metabolic 
modulations associated with improved physical 
performance. So opens notorious perspective to 
research this use. 
Methods
Sample
It was used forty Wistar rats (Rathus novergicus 
var, albinus, Rodentia, Mamalia) at 3 months of age, 
weighing 180-200 grams, from the Vivarium of the 
Methodist University of Piracicaba - UNIMEP and 
kept in the vivarium of the Faculty of Health Sciences 
(FACIS-UNIMEP) under ambient temperature of 
23°C ± 2°C, submitted to light/dark cycle of 12 h light, 
water and food ad libitum.
The study lasted 15 days, the mice were ran-
domly divided into four experimental groups (ten 
animals per group): 1) Control (C); 2) Stressed 
by swimming (E); 3) Treated with Metformin 
(M); 4) Treated with Metformin and stressed 
by swimming (ME). All procedures used in this 
study were in accordance with the principles of 
handling and care of laboratory animals recom-
mended by COBEA (Brazilian College of Animal 
Experimentation) and approved by the Ethics 
Committee on Animal Use of UNIMEP protocol 
number 09/2013.
Metformin treatment
The experimental groups treated with metformin 
received the substance by the orogastric via at the 
concentration of 1.4 mg/ml during 15 days. This 
concentration was chosen following proposal that 
showed no toxicity at this concentration14. Fur-
thermore, considering that the animal body weight 
changed by 180–200 grams, the correction of that 
delineated dosage for a 70 kg man would denote 
range of 490-544 mg, like the also delineated for 
insulin resistant individuals.
Stress induced condition 
After fifteen days of metformin treatment in ME 
group and without metformin treatment in the 
E group, the animals underwent a single session 
acute exercise by swimming for 50 minutes in low 
intensity, performed in a tank containing water at 
30 ± 2ºC15-16. The training sessions were drawn 
without the use of additives, which corresponds to 
an intensity below the anaerobic threshold, or to 
a predominantly aerobic stress, according to prior 
publication17. Such volume and the intensity chosen 
are justified by the fact that the same are applicable 
to individuals, apparently healthy and beginners in 
the physical exercise.
Biochemical reviews
The animals were anesthetized with sodium 
pentobarbital (40mg/Kg, ip) immediately after the 
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exercise and the blood was collected by renal artery, 
this blood was centrifuged and the plasma was sepa-
rated for evaluation of plasma glucose concentration 
by an enzymatic kit Labortest, corticosterone was 
performed by immunoassay kit from Assay Designs® 
(Ann Arbor, MI, USA). The following samples of 
liver, soleus and gastrocnemius white portion were 
carefully isolated and removed for determination 
of glycogen content by the phenol sulfuric acid 
method18.
Histological analysis
For histological analysis of the liver, its ventral 
segment was fixed and then processed from which 
various cross-sections of non-serial 5μm thick, 
which were stained using hematoxylin-eosin (HE) 
were obtained.
Statistical analysis
The collected data were tabulated and analyzed 
using the statistical software “GraphPad Prism 
6”. Statistical analysis was performed by applying 
the Shapiro-Wilk test to verify the normality of 
the data.
Thus, for comparisons between groups, the 
statistical test for analysis of variance (one-way 
ANOVA) followed by Tukey-Kramer multiple 
comparisons for parametric data. In all cases 
we adopted a value of p < 0.05 for statistical 
significance.
Results
Were observed that glycogen stores of soleus 
muscle were depleted by 60% due to the stress-in-
ducing condition (E). On the other hand, in the 
group treated with metformin (M) the glycogen 
content presented was 19% higher compared to the 
control (C). In the group treated with metformin 
and subjected to acute exercise (ME) was observed 
that the glycogen content was 89% higher when 
compared to untreated and exercised group (E) 
(FIGURE 1).
Moreover, it is noted that behavior of muscle 
glycogen reserves of gastrocnemius white portion, 
on different experimental conditions, was 69% 
lower because of acute exercise (E). In turn, it is 
noteworthy that there was an increase of 21% on 
glycogen reserves in the group treated with met-
formin (M). In assessing, the group treated with 
metformin and subjected to acute exercise (ME) it 
was found that glycogen reserves showed up 150% 
larger compared to untreated and exercised group 
(E) (FIGURE 1).
After that, the hepatic glycogen content was 
evaluated, and found that the acute exercise de-
creases the reserves in 84% (E) if compared to 
the control group (C). In the group treated with 
metformin (M) the hepatic glycogen reserves 
was increased in 57%, on the other hand, in 
the metformin group subjected to acute exercise 
(ME) the reserves were 368% higher when com-
pared to untreated and exercised group (E). In 
this condition, the values  were 26% lower in ME 
compared to the content observed in the control 
group (C) (FIGURE 1).
In assessing of blood glucose was found that 
acute exercise (E) promoted an increase of 99.4% 
compared to the control group (C).  In the group 
treated with metformin (M), the values showed 
no significant difference if compared to the con-
trol group (C). Already the treated and exercised 
group (ME) showed 38% lower blood glucose if 
compared to untreated and exercised group (E) 
(FIGURE 1).
Within the endocrine profile, plasma corticos-
terone was evaluated and observed that treatment 
with metformin did not change the plasma con-
centration. On the other hand, the acute exercise 
group showed (E) a significant increase of 185% in 
the plasma concentration if compared to control 
group (C), something observed in the treated and 
exercised group (ME), but ME had lower concen-
trations of corticosteroids if compared to untreated 
and exercised group (E) (FIGURE 1).
The histological analysis of hepatic glycogen 
content can show the glycogen granules, which are 
more abundant on the hepatocytes in treated group 
(M) and treated/exercised group (ME). In the 
liver of exercised animals (E), there was depletion 
of granules mainly in the periportal region. The 
same did not occur with the same intensity in the 
treated and exercised group (ME), indicating lower 
reserve mobilization in the presence of biguanide 
(FIGURE 2).
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The results are ex-
pressed as the mean ± 
SD, n=10, C = Control, 
M = Treated with Met-
formin, E = Exercised by 
swimming, ME = Treat-
ed with Metformin and 
exercised by swimming. 
*p < 0,05 comparing with 
group C; #p < 0,05 com-
pared with group M; .ψp 
< 0,05 compared with 
group E. 227x293mm 
(300 x 300 DPI)
FIGURE 1 - Content of muscle glycogen, hepatic glycogen, plasma glucose and corticosterone concentration of 
experimental groups.
Discussion
The interrelationships between carbohydrate 
metabolism in the liver and muscles are studied by 
different scientists, since the energy reserves are deter-
minants of resistance at physical exercise19. However, 
it has been noted modifications at the mobilization 
of these reserves concomitant to elevation at physical 
activity, stress or in the presence of some drugs that 
modify metabolic homeostasis of the organism20.
Initially we studied the effects of acute exercise in-
duced by inescapable forced swim for 50 minutes in low 
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In the liver of the 
animals in group E, 
there was depletion 
of glycogen granules, 
mainly in the periportal 
region (arrow). This did 
not occur in the group 
ME (arrow) (100x, PAS). 
C = Control, M = Treat-
ed with Metformin, E = 
Exercised by swimming, 
ME = Treated with Met-
formin and exercised by 
swimming. 150x133mm 
(200 x 200 DPI)
FIGURE 2 - Histology of the liver of experimental groups. Glycogen is evidenced by beads and are most abundant 
in hepatocytes of the treated groups (M and ME).
intensity, proposed by Sampaio-Barros et al.15, which 
corresponds to an intensity below the anaerobic thresh-
old, or to a predominantly aerobic stress, according to 
prior publication17, on liver and muscle glycogen re-
serves. The data show that acute exercise condition can 
cause an intense depletion of hepatic glycogen stores 
(FIGURE 1), and can be explained by the increase in 
the neuroendocrine axis activity, represented by the 
increase in the secretion of epinephrine and norepi-
nephrine, which activate adrenoceptor determining 
glycogenolysis in hepatocytes21. Occurs sequentially 
increase in the secretion of growth hormone, glucagon, 
adrenocorticotropic hormone, prolactin and opioid 
peptides, which also manifest glycogenolytic action, 
characterizing a synergistic effect22.
In order to avoid doubts and characterize the 
acute exercise, plasma corticosterone was evaluated 
and showed an increase in its concentration after 
physical training session (FIGURE 1), reflecting 
the activation of the neuroendocrine axis23.
With respect to muscle glycogen reserves, it was 
observed that due to the increase in energy require-
ments generated by the inducing acute exercise 
condition the reserves were depleted (FIGURE 1). 
These results corroborate with recent studies, which 
suggest that the intensity and duration of the stressor 
may modulate the utilization of energy substrates, 
with a special energy source, the degradation of 
muscle glycogen15,24-25.
Thus, metformin was used in this study to verify 
its efficiency in conditions of acute exercises, based 
on published reports that indicate that the bigua-
nide promotes a significant improvement in muscle 
glucose metabolism26-28.
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It has been suggested that metformin does not 
alter the phosphorylation of the insulin receptor, 
and its centralized action in the post-receptor 
phenomena, where the biguanide promotes a rise 
in glucose uptake level, preserves the sensitivity of 
hepatocytes to insulin to regulate the activity of ty-
rosine kinase bound to the receptor, it enhances the 
dynamics of glucose uptake favoring the formation 
of glycogen reserves29.
In muscle, AMPK activation by metformin pro-
motes the use of glucose, this increases the enzyme 
activity, causing the GLUT-4 translocation to the 
plasma membrane, promoting an increase in the ac-
tivity of hexokinase and glycogen content in muscle 
cells. In addition, fatty acids undergo oxidation and 
reduction of the synthesis30.
In the liver, AMPK activation inhibits transcrip-
tion of enzymes phosphoenolpyruvate car-boxiqui-
nase (PEPCK) and glucose-6-phosphatase (G6Pase), 
generating a reduction in gluconeogenesis27. In vitro 
and in vivo studies demonstrated that phosphory-
lation of AMPK, caused by metformin, are mod-
ulated by the OCT1 activity, suggesting that this 
transporter has a key role in the cascade of events 
that result in decreased hepatic gluconeogenesis28. 
In addition, AMPK also promotes improvement in 
lipid metabolism during treatment with metformin, 
so that activation of this enzyme inhibit acetyl-CoA 
carboxylase (ACC) and 3-hydroxy-3-methylglu-
taryl-coenzyme and reductase (HMG-CoA reduc-
tase), key enzymes in the synthesis of triglycerides 
and cholesterol, respectively22,29,31. In addition, 
AMPK activation in the liver also suppresses the 
expression of SREBP-1 and SREBP-1c genes, which 
are involved in the pathogenesis of insulin resistance, 
dyslipidemia and diabetes mellitus 231.
It’s permissive to suggest that considering such 
molecular mechanisms associated with capita-
tion of glucose by peripheral tissues resulting 
from metformin, this one has the potential to 
improve performance in physical exercise in pre-
dominantly aerobic conditions, due to increased 
energy substrate availability to meet demand from 
the effort. This increased availability of glucose 
to satisfy the demand of the aerobic effort, is 
crucial, since for metabolizing fats, requiring 
the continuous creation of oxaloacetate, recog-
nized this metabolite is synthesized from own 
glucose32. In his line of thought, studies with 
animal models has shown that skeletal muscle 
and liver glycogen reserves are related to higher 
physical performance, resulting in the increase in 
the threshold exhaustion, specifically against the 
effort in aerobic condition33-34.
The assessment of hepatic glycogen content of 
rats treated with metformin (M) showed that stocks 
were high (FIGURE 1), the histological analysis 
showed it too (FIGURE 2), and is due to metformin 
suppress hepatic gluconeogenesis and activate the 
mechanisms of glycogen synthesis by activating en-
zymes flag system at the level of insulin post-recep-
tor, especially the enzyme via phosphatidyl-inositol 
3 kinase (Pi-3K) and glycogen synthase31. Similar 
finding was observed in muscles treated with the 
biguanide, which also showed an increase in the 
concentration of glycogen synthesis whose actions 
should be elevated post-insulin receptor, similar 
to that described in hepatocytes35-37. It is worth 
mentioning that mice treated with metformin (M) 
showed no change in the secretion of corticosterone 
(FIGURE 1), showing specificity in the action of 
the biguanide metabolic adjustment.
In the experimental result we started to evaluate 
the hepatic and muscle glycogen reserves of rats 
treated with metformin undergoing inducing acute 
exercise condition (ME) being observed that the re-
serves were significantly higher than those observed 
in the untreated and exercised group (E) (FIGURE 
1). This result shows that the glycogenic activity of 
metformin gave better energy conditions both in liv-
er as skeletal muscle, leading to a different reaction 
when animals to stressful conditions and yet, the 
plasma concentration of glucose and corticosterona 
were lower compared to untreated and exercised 
group (E) (FIGURE 1), culminating in increased 
fatigue threshold and, consequently, increasing the 
time to exhaustion, due to the delay in decrease of 
muscle and liver glycogen. This suggests that the 
treatment led to an increased resistance against acute 
exercises indicating that there may be a correlation 
between the energy status and response to physio-
logical stress in the conditions of this study, with a 
session of swimming for 50 minutes in low intensity.
A limitation of the present study was the fact that 
the analysis of the evaluated parameters occurred 
under acute exercise by swimming condition. Thus, 
if the evaluations of these parameters had occurred 
under a chronic training condition, would surely 
bring greater subsidies for understanding the use 
of metformin.
Concluding, metformin treatment modified the 
metabolic responses classically observed against 
acute exercises conditions providing greater re-
sistance exercise confirming the study hypothesis 
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initially proposed. It is noteworthy that the limit-
ing factor of this study is the fact that the effects 
of the supplementation were evaluated solely on 
condition of acute stress. In this sense, future 
studies are which would be required, focusing on 
analysis of the chronic effects of such supplementa-
tion and during subsequent training sessions. Once 
the biguanide is not metabolized and is excreted 
in pharmacological form, this component still 
induces an increase of muscle and liver glycogen, 
enabling greater endurance. Furthermore, whereas 
a period of 15 days of supplementation with met-
formin, in eutrophic animals, has the potential to 
maximize the metabolic responses to acute stress 
by maintaining liver and musculoskeletal glycogen 
stores. Thus, it is necessary that the readily Word 
Anti-Doping Agency develop a technique for the 
diagnosis of use of metformin in order to identify 
a possible frame of doping. Further studies are 
required, and the physical therapists and fitness 
trainers shall see that the substance should not be 
used as an ergogenic agent.
Resumo
Reservas hepáticas e musculares de glicogênio de ratos tratados com metformina e submetidos ao exercício 
agudo por natação
O objetivo deste estudo foi avaliar o comportamento das reservas glicogênicas de ratos, submetidos a 
uma condição de exercício agudo (50 minutos de natação na intensidade leve), após o tratamento com 
metformina. Quarenta ratos Wistar (180-200g) adultos foram divididos em quatro grupos (tratados ou não 
por quinze dias) e assim representados: Controle; Exercício agudo por natação (realizaram uma sessão de 
natação, sendo 50 minutos na intensidade leve); Tratado com metformina (receberam o fármaco metfor-
mina na dosagem de 1,4 mg/ml, durante o período experimental; Tratados com metformina e submetidos 
a condição exercício agudo por natação (receberam o fármaco metformina na dosagem de 1,4 mg/ml e 
realizaram uma sessão de natação, sendo 50 minutos na intensidade leve). O exercício agudo diminuiu 
as reservas glicogênicas, já os animais tratados com metformina, apresentaram um aumento em suas 
reservas glicogênicas musculares e hepáticas em relação ao grupo que realizou o exercício sem suple-
mentação (p<0,05). Adicionalmente, o fármaco demonstrou não aumentar a glicemia e a concentração 
de corticosterona em relação ao grupo controle e suplementado com metformina (p>0,05). O tratamento 
com metformina promoveu melhora nas condições energéticas e menor resposta ao estresse, sugerindo 
ser uma importante ferramenta farmacológica para a potencialização da performance.
Palavras-chave: Glicogênio; Desempenho; Biguanida; Ratos.
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